---
title: "New Medication for Alzheimer's Disease: What you need to know about Aducanumab"
date: 2021-08-25T00:35:35+0100
author: matt
draft: True
---
Aducanumab (Aduhelm), a new drug designed to treat Alzheimer's disease was approved by the FDA on June 7, 2021. RGA's Dr. Dave Rengachary discusses what this means for insurance, as well as the controversies around it.
 

[ New Medication for Alzheimer's Disease: What you need to know about Aducanumab ]( https://www.rgare.com/knowledge-center/media/articles/what-you-need-to-know-about-aducanumab )
